Admission Date:  [**2137-1-7**]       Discharge Date:  [**2137-1-16**]  Date of Birth:   [**2137-1-7**]       Sex:  F  Service:  Neonatology HISTORY OF PRESENT ILLNESS:  Baby Girl [**Known lastname 46**] is the 2,125 gram product of a 34 week gestation, born to a 32 year old primiparous mother, born by cesarean section.
The pregnancy was complicated by cerclage placement at 18 weeks and hypertension, prompting bed rest for the two weeks prior to Prenatal screens were unremarkable, group B streptococcus unknown at the time of delivery.
The infant was delivered by cesarean section for failure to progress.
Given blow-by oxygen and stimulation.
The infant received a total of two doses of surfactant and extubated to nasal prong C-PAP at 24 hours of age, where she remained for a total of 48 hours.
She then progressed to nasal cannula oxygen, where she remained for 72 hours and has been stable in room air for the remainder of her hospital course.
Cardiovascular:  Initially required two normal saline boluses for support of her blood pressure needs.
Enteral feedings were initiated on day of life number one.
feeding breast milk or Enfamil 24 calories, taking in adequate amounts.
The patient was treated with phototherapy for two days.
The patient has not required any blood transfusions during this hospital course.
Antibiotics were initiated with ampicillin and gentamicin.
At 48 hours, blood cultures remained negative and antibiotics were discontinued.
The patient was started on Nystatin oral suspension on [**2137-1-15**] for evidence of thrush.
DISCHARGE MEDICATIONS: Nystatin oral suspension p.o.
Immunizations received:  The infant received her hepatitis B vaccine on [**2137-1-15**].
Immunizations recommended: 1.
Synagis RSV prophylaxis should be considered from [**Month (only) 359**] through [**Month (only) 547**] for infants who meet any of the following three criteria:  (1) Born at less than 32 weeks gestation; (2) born between 32 and 35 weeks with plans for day care during RSV season, with a smoker in the household or with preschool siblings or; (3) with chronic lung disease.
Influenza immunization should be considered annually in the fall for preterm infants with chronic lung disease once they have reached six months of age.
Before this age, the family and other care givers should be considered for immunization against influenza to protect the infant.
Mild respiratory distress syndrome, treated with surfactant, resolved.
